MedTrace Logo

Identification of Pathogens in the Neonatal Intensive Care Unit (NICU)

NCT03077100 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2017-03-10

No results posted yet for this study

Summary

To aim of this study is to identify the pathogens and their distribution in the NICU and to determine whether empirical antibiotics are suitable for the treatment of sepsis in the unit.

Conditions

  • Pathogen Resistance

Interventions

OTHER

Laboratory identification of positive cultures

Laboratory identification of positive cultures

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Principal Investigators

  • Michael Feldman, MD · Hillel Yaffe Medical Center

Eligibility

Max Age
3 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-31
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03077100 on ClinicalTrials.gov